Pharvaris BV (PHVS)

$19.41 $0.29 (1.54%) 4:38 PM 12/11/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $1.03B
  • Day's Range

    $18.16 - $19.32
  • Volume

    136,611
  • 52 Week Low / High

    $15.37 - $33.00
  • PE Ratio

    -
  • PEG Ratio

    -
  • Dividend Frequency

    -

PHVS's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
4
Strong Buy
2
Buy
0
Hold
1
Sell
0
Strong Sell
$24.15
Target Price

Company News

  • Pharvaris to Participate in the Leerink Global Biopharma Conference 2024 — Mar 5th, 2024

    Pharvaris N.V. ZUG, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced that its management will participate i...

Similar Stocks

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free